Gregory Conko is a Senior Fellow at the Competitive Enterprise Institute, a Washington, DC-based public interest group. His research at CEI focuses on issues of food and pharmaceutical drug safety regulation, and on the general treatment of health risks in public policy. He is particularly interested in the debate over the safety of biotechnology and bioengineered foods, as well as the application of the Precautionary Principle to domestic and international environmental and safety regulations.
Mr. Conko is also the Vice President and a member of the
Board of Directors of the Auburn, Alabama-based AgBioWorld Foundation, a
non-profit organization he co-founded in 2000 with
Mr. Conko’s book, The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution (Praeger, 2004), co-authored with Henry I. Miller, was named by Barron’s as one of the 25 best books of 2004. His other writings have appeared in such journals as Nature Biotechnology, Transgenic Research, Politics and the Life Sciences, the Richmond Journal of Law & Technology, and the Cumberland Law Review, and in such newspapers as the Financial Times, The Wall Street Journal Europe and Asian Wall Street Journal, Los Angeles Times, and the San Francisco Chronicle. He has appeared on numerous television and radio programs as a commentator on public health and consumer safety issues, and he frequently participates in international meetings on food safety and trade as a credentialed Non-Governmental Organization representative.
Mr. Conko is a member of the Board of Scientific and Policy
Advisors for the New York-based American Council on Science and Health. He
served as a principal investigator for the California Council on Science and
Technology’s 2002 report Benefits and
Risks of Food Biotechnology. He was selected by the American Swiss
Foundation as one of 25 Young Leaders from the
Prior to joining CEI in 1994, Mr. Conko was a Research
Associate with the
Book as Speaker
Read All Publications by Expert.
recent op-eds & articles
Eliminating Antitrust Exemption Will Kill Health Care Competition
By Gregory Conko, Kevin Hilferty, November 4, 2009
FDA's Bad Medicine
By Gregory Conko, Jerome Arnett, June 17, 2009
Will Americans (Literally) Be Dying For ObamaCare?
By Gregory Conko, Henry I. Miller, June 12, 2009
Supreme Court Botches Preemption Case
By Gregory Conko, April 1, 2009
Needle and the Damage Done
By Gregory Conko, March 18, 2009
recent studies
Congressional Misdiagnosis
By Gregory Conko, Kevin Hilferty, December 8, 2009
A Cure Worse than the Disease
By Gregory Conko, October 22, 2009
FDA and Internet Advertising
By Arnold Friede, Gregory Conko, October 6, 2009
Political Malpractice
By Gregory Conko, September 8, 2009
Black Box Panic
By Gregory Conko, Jerome Arnett, March 3, 2009
news release
Supreme Court Botches Preemption Case
By Gregory Conko, March 4, 2009
The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution
By Gregory Conko, Henry I. Miller, August 20, 2004
Scientists and Scholars Denounce Position of the Catholic Institute for International Relations on GM Crops
By Gregory Conko, July 19, 2004
CEI Comments Before FDA on Bioengineered Foods
By Gregory Conko, May 4, 2001
recent citations
Gregory Conko on Christmas Comes Early for the Big Drug Companies
The Washington Examiner, Dec. 23, 2009
Gregory Conko on Premiums to Skyrocket Under ObamaCare
Newsmax.Com, Oct. 29, 2009
Gregory Conko on Draft Guidance on Drug, Device Ads Needs Revisions, Stakeholders Tell FDA
The Bureau of National Affairs, Aug. 26, 2009
Gregory Conko on FDA Drug approval delays; new drug called Provenge
Investor’s Business Daily, Apr. 24, 2009
Gregory Conko on Supreme Court’s decision in Wyeth v. Levine
ABC News, Mar. 4, 2009

